fingolimod hydrochloride has been researched along with Cancer of Colon in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, DJ; Lee, YM; Oh, YS; Park, EY; Shamshiddinova, M; Shrestha, J | 1 |
| Han, Y; Ma, DH; Wang, ZH; Xing, Y | 1 |
| Chen, G; Feng, J; Guo, R; Han, G; Hou, C; Li, Y; Lv, Z; Ma, Y; Morris, JC; Ning, C; Shen, B; Taylor, EN; Wang, R; Wang, Y; Xiao, H; Zhou, T | 1 |
| Fujita, T; Nagaoka, Y; Otsuki, K; Uesato, S | 1 |
4 other study(ies) available for fingolimod hydrochloride and Cancer of Colon
| Article | Year |
|---|---|
SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway.
Topics: Apoptosis; Ceramides; Colonic Neoplasms; Colorectal Neoplasms; Fingolimod Hydrochloride; Humans; RNA, Small Interfering | 2022 |
FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fingolimod Hydrochloride; Gene Expression; Humans; Immunosuppressive Agents; Propylene Glycols; Sphingosine | 2014 |
The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
Topics: Animals; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Fingolimod Hydrochloride; Hematopoiesis, Extramedullary; Humans; Immunosuppressive Agents; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Myeloid Cells; Tumor Microenvironment | 2017 |
Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Enzyme Inhibitors; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Indicators and Reagents; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Spectrophotometry, Infrared; Sphingosine | 2008 |